Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25- hydroxyvitamin D3

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 5, 1998, Pages 391-395

  Schwartz, Gary G ^a   Whitlatch, Lyman W ^c   Chen, Tai C ^c   Lokeshwar, Bal L ^b   Holick, Michael F ^c  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; OXYGENASE;

ANIMAL CELL; ARTICLE; CALCIUM HOMEOSTASIS; CANCER CELL CULTURE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; KERATINOCYTE; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; VITAMIN D METABOLISM;

ADULT; CALCIFEDIOL; CALCITRIOL; CELLS, CULTURED; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031927920     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Walter, M. R. Newly identified actions of the vitamin D endocrine system. Endocr Rev , 13: 719-764, 1992
2. Holick, M F. Vitamin D. Biosynthesis, metabolism, and mode of action In: L. J DeGroot (ed.), Endocrinology, Ed 3., pp. 990-1014 Philadelphia: W. B Saunders. 1995.
3. Barbour, G L , Coburn, J. W., Slatopolsky, E , Norman, A. W , and Horst, R. L. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D N Engl J. Med., 305: 440-443, 1981.
4. 3 production by human keratinocytes Kinetics and regulation. J Clin. Invest, 78. 557-566, 1986
5. Dusso, A., Brown, A., and Slatopolsky, E. Extrarenal production of calcitriol. Semin. Nephrol., 14: 144-155, 1994.
6. Bouillon, R., Garmyn, M , Verstuyf, A., Segaert, S., Casteels, K., and Mathieu, C Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogs Eur. J. Endocrinol , 133: 7-16, 1995.
7. Schwartz, G. G., and Hulka, B. S. Is vitamin D deficiency a risk factor for prostate cancer (hypothesis)? Anticancer Res , 10. 1307-1311, 1990.
8. 3 Cancer Res., 52. 515-520, 1992.
9. 3 receptors and actions in human prostate cancer cell lines. Endocrinology, 132: 1952-1960, 1993.
10. Zhuang, S-H., Schwartz, G. G , Cameron, D., and Burnstein. K. L. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cells. Mol Cell. Endocrinol , 126: 83-90, 1997.
11. Schwartz, G G., Oeler, T. A , Uskokovic, M. R., and Bahnson. R. R Human prostate cancer cells: inhibition of proliferation by vitamin D analogs. Anticancer Res, 14: 1077-1082, 1994.
12. 3 on primary cultures of human prostatic cells. Cancer Res., 54: 805-810, 1994
13. 3 in seven human prostatic carcinoma cell lines. Clin Cancer Res., 1: 997-1003, 1995
14. Konety, B. R , Schwartz, G. G., Acierno, J. S., Jr., Becich, M J , and Getzenberg, R. H. The role of vitamin D in normal prostate growth and differentiation Cell Growth Differ., 7: 1563-1570, 1996.
15. Lokeshwar, B. L , Selzer, M. B , Block, N. L., and Gunja-Smith, Z Secretion of matrix metalloproteinases and their inhibitors (TIMPs) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res., 53: 4493-4498, 1993.
16. Taylor-Papadimitriou, J , and Stampher, M. R. In: I R Freshney (ed.), Culture of Epithelial Cells, pp. 107-133 New York Wiley-Liss, 1992.
17. Rheinwald, J G., and Green, H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell, 6. 331-344, 1975.
18. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions J Invest. Dermatol , 86: 709-714, 1986.
19. 3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes J. Invest. Dermatol., 104: 113-117, 1995.
20. 3 in vivo and in primary cultures of chick kidney cells. J. Biol. Chem., 254. 2722-2729, 1979.
21. 3-1α-and 24R-hydroxylases. Endocrinology, 125: 1224-1230, 1989.
22. Adams, J S , Beeker, T. G , Hongo, T , and Clemens, T. L Constitutive expression of a vitamin D-hydroxylase in a myelo-monocytic cell line: a model for studying 1,25-dihydroxyvitamin D production in vitro J. Bone Mineral Res., 5. 1265-1269, 1990
23. Adams, J S., Gacad, M A., DIZ, M M., and Nadler, J. L. A role for endogenous arachidonate metabolites in the regulated expression of the 25-hydroxy vitamin D1-hydroxylated reaction of cultured alveolar macrophages from patients with sarcoidosis. J Clin. Endocrinol. Metab., 70: 595-600, 1990
24. Chen. T. C., Turner, A. K , and Holick, M. F. A method for determination of the circulating concentration of 1,25-dihydroxyvitamin D J. Nurtr. Biochem., 1: 320-327, 1990.
25. Hollis, B W. Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure. Clin Chem., 32: 2060-20063, 1986.
26. 3 by solubilized kidney mitochondria from chick and rat. J. Biol Chem , 260: 14132-14136, 1985.
27. Bradford, M. M A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Ann. Biochem , 72: 248-254, 1976
28. Favus, M. J., and Langman, C. B. Evidence for calcium-dependent control of 1,25-dihydroxyvitamin D3 production by rat kidney proximal tubules. J. Biol. Chem , 261 11224-11229, 1986.
29. 3 1α and 24-hydroxylase along the rat nephron. Proc Natl. Acad. Sci. USA, 78: 1199-1203, 1981
30. 3 by a human small cell lung cancer cell line. J Clin. Endocrinol Metab., 79: 554-560, 1994
31. 3 metabolism by human T-lymphocyte virus-transformed lymphocytes J Clin Endocrinol. Metab., 65: 1-9, 1987.
32. 3. J Biol. Chem., 256: 7738-7740, 1981
33. Chen, T. C, Curthoys, N. P., Lagenaur, C. F., and Puschett, J. B. Characterization of primary cell cultures derived from rat renal proximal tubules. In Vitro Cell. Develop Biol., 25: 714-722, 1989.
34. Schwartz, G. G., Wang, M-H., Zhang, R. K., and Siegal, G. P. 1α,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomark Prev., 6: 727-732, 1997
35. Hanchette, C. L , and Schwartz, G. G. Geographic patterns of prostate cancer mortality: evidence for a protective effect of ultraviolet radiation Cancer (Phila.), 70: 2861-2869, 1992
36. Schwartz, G. G. Prostate cancer and the vitamin D hypothesis. In: M F. Hohck and E. G. Jung (eds), Biological Effects of Light 1995, pp. 309-316. Berlin Walter de Gruyter, 1996.
37. Chesney, R. W , Rosen, J. F., Hanstra, A. J , Smith, C., Mahaffey, K . and DeLuca, H F. Absence of seasonal variations in serum concentrations of 1,25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer J. Clin Endocnnol. Metab, 53: 139-143, 1981.
38. Dusso, A., Finch, J., Delmez, J., Rapp, H., Lopez-Hilker, S., Brown, A , and Slatopolsky, E Extrarenal production of calcitriol Kidney Int., 38 (Suppl. 29): S-36-S-40, 1990
39. Corder, E H , Guess, H. A., Hulka, B. S., Friedman, G D., Sadler, M., Vollmer, R. T., Lobaugh, B., Drezner, M. K., Vogelman, J. H., and Orentreich. N. Vitamin D and prostate cancer: a prediagnostic study with stored sera Cancer Epidemiol. Biomark Prev., 2. 467-472, 1993.
40. Gann, P H., Ma, J , Hennekens, C. H., Hollis, B. W., Haddad, J. G., and Stampfer, M. J Circulating vitamin D metabolites in relation to subsequent development of prostate cancer Cancer Epidemiol. Biomark. Prev., 5: 121-126, 1996.
41. Geller, J , De LaVega, D. J , and Albert, J D. Tissue dihydrotestosterone levels and clinical response to hormone therapy in patients with prostate cancer. J Clin Endocrinol Metab , 58: 36-40, 1984.
42. Schwartz, G. G., Lokeshwar, B L . Selzer, M., Block, N , and Binderup, L. 1,25-Dihydroxyvitamin D and EB1089 inhibit prostate cancer metastasis in vivo In. Vitamin D Chemistry, Biology and Clinical Applications of the Steroid Hormone, pp. 489-490 Riverside, CA: University of California. 1997.
43. Osborne, J. L , Schwartz, G G., Smith, D. C., Bahnson. R R , Day, R., and Trump, D. L. A phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer. Urol. Oncol., 1: 195-198, 1995